UPDATED TIME: FRC's Tony Perkins to Hold News Conference Call Following House Vote on Stupak/Pitts Amendment
More News related to Press Releases
- Feature Film PUNCTURED HOPE Enlightens and Thrills Audiences on its Way to Awards Season
- Financial Facts Reports on Widespread Consumer Mistrust as Credit Card Transactions Drop 27%
- Celebrate an Affordable Thanksgiving With mydeco.com Homewares
- Adobe Enhances Acrobat.com with New Productivity and Collaboration Capabilities
- Jean Rah Fya Records Recording Artist Bobby Tinsley Wins for Best R&B/Soul Artist at the 2009 HMMA Awards!
*** Please Note Conference Call Time Change***
Washington, D.C. - Today, Saturday, November 7, 2009, Family Research Council (FRC) President Tony Perkins will host a media conference call responding to the House vote on the Stupak-Pitts-Dahlkemper-Lipinski-Kaptur-Smith amendment which will determine whether abortion funding will remain in the health care overhaul bill. The conference call will take place one half hour after the vote on the abortion funding amendment. Perkins will detail the next steps in the fight to ensure the health care bill does not force taxpayers to pay for abortions for the first time in over three decades.
(Logo: http://www.newscom.com/cgi-bin/prnh/20080930/FRCLOGO )
Speaker Nancy Pelosi's health care bill currently authorizes the government run "public option" to fund elective abortion and would subsidize private plans that cover elective abortion.
Who: Tony Perkins, President of the Family Research Council
Tom McClusky, Senior Vice President for FRC Action
Cathy Ruse, Senior Fellow for Legal Studies at the Family Research Council
What: Media Conference Call on House Vote on Stupak/Pitts Abortion Funding Amendment
When: 30 Minutes Following the House Vote on the Stupak/Pitts Amendment
Saturday, November 7, 2009 (or Sunday should the vote be postponed)
How: 1-866-939-8416
Participant Code 147917#
CONTACT: J.P. Duffy, +1-202-468-5265
SOURCE Family Research Council
Stocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
